Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Transparency in All Health Care Pricing Act of 2019
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1409, Cancer Drug Coverage Parity Act
Elijah E. Cummings Lower Drug Costs Now Act
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers S. 1895, Lower Healthcare Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2020 · first_quarter · 1T
Hematology research, prevention and public health programs Sickle Cell Disease Surveillance, HRSA Demonstration program on Sickle Cell disease FY2021 Labor HHS Appropriations
HR 1409, Cancer Drug Coverage Parity Act
Source: Senate LDA
| GAY MEN'S HEALTH CRISIS |
| 12 |
| 2011–2012 |
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Efforts to repeal and/or replace Affordable Care Act S.1895 Lower Health Care Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
reimbursement for hemophilia services and treatments Medicaid reimbursement for treatments for hemophilia patients S.3233/HR5952 Hemophilia SNF Access Act. Medicare, Medicaid and other policy changes due to the COVID emergency. Medicare Coverage and Reimbursement of drugs Medicaid coverage policy S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Surprise medical billing
Elijah E. Cummings Lower Drug Costs Now Act
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug Reimbursement Drug Pricing Issues S.3233/HR5952 Hemophilia SNF Access ActS.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Medicare, Medicaid and other policy changes due to the COVID emergency
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Medicare reimbursement for physician and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule, CAR-T Therapy Coverage & Reimbursement S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 language on Medicare, Medicaid and other policy changes due to the COVID emergency.
Elijah E. Cummings Lower Drug Costs Now Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act S 1895, Lower Healthcare Cost Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Hemophilia SNF Access Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
reimbursement for hemophilia services and treatments Medicaid reimbursement for treatments for hemophilia patients S.3233/HR5952 Hemophilia SNF Access Act. Medicare, Medicaid and other policy changes due to the COVID emergency. Medicare Coverage and Reimbursement of drugs Medicaid coverage policy S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Surprise medical billing
Hemophilia SNF Access Act
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug Reimbursement Drug Pricing Issues S.3233/HR5952 Hemophilia SNF Access ActS.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Medicare, Medicaid and other policy changes due to the COVID emergency
Lower Health Care Costs Act
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers S. 1895, Lower Healthcare Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Lower Health Care Costs Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Efforts to repeal and/or replace Affordable Care Act S.1895 Lower Health Care Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Lower Health Care Costs Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act S 1895, Lower Healthcare Cost Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
reimbursement for hemophilia services and treatments Medicaid reimbursement for treatments for hemophilia patients S.3233/HR5952 Hemophilia SNF Access Act. Medicare, Medicaid and other policy changes due to the COVID emergency. Medicare Coverage and Reimbursement of drugs Medicaid coverage policy S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Surprise medical billing
Prescription Drug Pricing Reduction Act of 2019
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Medicare reimbursement for physician and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule, CAR-T Therapy Coverage & Reimbursement S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 language on Medicare, Medicaid and other policy changes due to the COVID emergency.
Prescription Drug Pricing Reduction Act of 2019
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act S 1895, Lower Healthcare Cost Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers S. 1895, Lower Healthcare Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Efforts to repeal and/or replace Affordable Care Act S.1895 Lower Health Care Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Hemophilia SNF Access Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
reimbursement for hemophilia services and treatments Medicaid reimbursement for treatments for hemophilia patients S.3233/HR5952 Hemophilia SNF Access Act. Medicare, Medicaid and other policy changes due to the COVID emergency. Medicare Coverage and Reimbursement of drugs Medicaid coverage policy S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Surprise medical billing
Hemophilia SNF Access Act
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug Reimbursement Drug Pricing Issues S.3233/HR5952 Hemophilia SNF Access ActS.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Medicare, Medicaid and other policy changes due to the COVID emergency
To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect.
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1010
To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect.
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lover Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act
To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect.
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lower Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 SJ Res 52; Public Charge
ENROLL Act of 2019
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lower Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 SJ Res 52; Public Charge
ENROLL Act of 2019
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lover Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act
Transparency in All Health Care Pricing Act of 2019
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1409, Cancer Drug Coverage Parity Act
Transparency in All Health Care Pricing Act of 2019
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1409, Cancer Drug Coverage Parity Act
Transparency in All Health Care Pricing Act of 2019
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1409, Cancer Drug Coverage Parity Act
Transparency in All Health Care Pricing Act of 2019
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1409, Cancer Drug Coverage Parity Act
Elijah E. Cummings Lower Drug Costs Now Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lower Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 SJ Res 52; Public Charge
Elijah E. Cummings Lower Drug Costs Now Act
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug Reimbursement Drug Pricing Issues Medicare Reimbursement of SNF Services S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Medicare reimbursement for physician and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule, CAR-T Therapy Coverage & Reimbursement S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Medicare Physician Fee Schedule for 2020 Proposed Rule
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Efforts to repeal and/or replace Affordable Care Act S.1895 Lower Health Care Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act S 1895, Lower Healthcare Cost Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
reimbursement for hemophilia services and treatments Medicaid reimbursement for treatments for hemophilia patients Medicare Reimbursement of SNF services Medicare Coverage and Reimbursement of drugs Medicaid coverage policy S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers S. 1895, Lower Healthcare Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers S. 1895, Lower Healthcare Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Medicare reimbursement for physician and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule, CAR-T Therapy Coverage & Reimbursement S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Medicare Physician Fee Schedule for 2020 Proposed Rule
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Efforts to repeal and/or replace Affordable Care Act S.1895 Lower Health Care Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug Reimbursement Drug Pricing Issues Medicare Reimbursement of SNF Services S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
reimbursement for hemophilia services and treatments Medicaid reimbursement for treatments for hemophilia patients Medicare Reimbursement of SNF services Medicare Coverage and Reimbursement of drugs Medicaid coverage policy S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Surprise medical billing
Protecting Americans with Preexisting Conditions Act of 2019
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lover Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act
Protecting Americans with Preexisting Conditions Act of 2019
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lower Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 SJ Res 52; Public Charge
Strengthening Health Care and Lowering Prescription Drug Costs Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lower Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 SJ Res 52; Public Charge
Strengthening Health Care and Lowering Prescription Drug Costs Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lover Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act
Lower Health Care Costs Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act S 1895, Lower Healthcare Cost Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Lower Health Care Costs Act
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers S. 1895, Lower Healthcare Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Lower Health Care Costs Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lover Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act
Lower Health Care Costs Act
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers S. 1895, Lower Healthcare Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Lower Health Care Costs Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Efforts to repeal and/or replace Affordable Care Act S.1895 Lower Health Care Costs Act
Lower Health Care Costs Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lower Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 SJ Res 52; Public Charge
Lower Health Care Costs Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Efforts to repeal and/or replace Affordable Care Act S.1895 Lower Health Care Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Lower Health Care Costs Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Efforts to repeal and/or replace Affordable Care Act S.1895 Lower Health Care Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Lower Health Care Costs Act
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers S. 1895, Lower Healthcare Costs Act
Prescription Drug Pricing Reduction Act of 2019
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
reimbursement for hemophilia services and treatments Medicaid reimbursement for treatments for hemophilia patients Medicare Reimbursement of SNF services Medicare Coverage and Reimbursement of drugs Medicaid coverage policy S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Surprise medical billing
Prescription Drug Pricing Reduction Act of 2019
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Medicare reimbursement for physician and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule, CAR-T Therapy Coverage & Reimbursement S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Medicare Physician Fee Schedule for 2020 Proposed Rule
Prescription Drug Pricing Reduction Act of 2019
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Efforts to repeal and/or replace Affordable Care Act S.1895 Lower Health Care Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act S 1895, Lower Healthcare Cost Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug Reimbursement Drug Pricing Issues Medicare Reimbursement of SNF Services S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Efforts to repeal and/or replace Affordable Care Act S.1895 Lower Health Care Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers S. 1895, Lower Healthcare Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lower Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 SJ Res 52; Public Charge
Prescription Drug Pricing Reduction Act of 2019
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug Reimbursement Drug Pricing Issues Medicare Reimbursement of SNF Services S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Medicare reimbursement for physician and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule, CAR-T Therapy Coverage & Reimbursement S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Medicare Physician Fee Schedule for 2020 Proposed Rule
Prescription Drug Pricing Reduction Act of 2019
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
reimbursement for hemophilia services and treatments Medicaid reimbursement for treatments for hemophilia patients Medicare Reimbursement of SNF services Medicare Coverage and Reimbursement of drugs Medicaid coverage policy S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers S. 1895, Lower Healthcare Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers".
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lower Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 SJ Res 52; Public Charge
Cancer Drug Parity Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1409, Cancer Drug Coverage Parity Act
Cancer Drug Parity Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1409, Cancer Drug Coverage Parity Act
Cancer Drug Parity Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1409, Cancer Drug Coverage Parity Act
Cancer Drug Parity Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1409, Cancer Drug Coverage Parity Act
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease; HR 2410/S 2465 SCD Research, Surveillance Prevention and Treatment Act of 2017
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease; HR 2410/S 2465 SCD Research, Surveillance Prevention and Treatment Act of 2017
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease; HR 2410/S 2465 SCD Research, Surveillance Prevention and Treatment Act of 2017
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease; HR 2410/S 2465 SCD Research, Surveillance Prevention and Treatment Act of 2017
Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
H.R. 6157 Labor-HHS-Appropriations Act for FY 2019 Funding for Hemophilia programs
Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 6157 - Department of Defense, Labor and HHS Appropriations Act, 2019 Hematology research, prevention and public health programs Sickle Cell Disease Surveillance
Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Labor-HHS-Education Appropriations Act 2019, HR 6157 Hemophilia program funding
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease; HR 2410/S 2465 SCD Research, Surveillance Prevention and Treatment Act of 2017
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease; HR 2410/S 2465 SCD Research, Surveillance Prevention and Treatment Act of 2017
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease; HR 2410/S 2465 SCD Research, Surveillance Prevention and Treatment Act of 2017
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease; HR 2410/S 2465 SCD Research, Surveillance Prevention and Treatment Act of 2017
Ensuring Coverage for Patients with Pre-Existing Conditions Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act S. 3388 - Ensuring Coverage for People with Pre-Existing Conditions Act
Ensuring Coverage for Patients with Pre-Existing Conditions Act
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act S. 3388 - Ensuring Coverage for People with Pre-Existing Conditions Act
Cancer Drug Parity Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1409, Cancer Drug Coverage Parity Act
Cancer Drug Parity Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1409, Cancer Drug Coverage Parity Act
Cancer Drug Parity Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1409, Cancer Drug Coverage Parity Act
Cancer Drug Parity Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1409, Cancer Drug Coverage Parity Act
American Health Care Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1628, American Health Care Act & HR 1628, Better Care Reconciliation Act and other efforts to Repeal & Replace the Affordable Care Act.
American Health Care Act of 2017
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act; HR 1628 American Health Care Act and other legislation to Repeal & Replace Affordable Care Act.
American Health Care Act of 2017
Client: ENDOCRINE SOCIETY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
American Health Care Act, HR 1628 Better Care Reconciliation Act, HR 6628 Graham-Cassidy Special Diabetes Program
American Health Care Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1628, American Health Care Act & other efforts to Repeal & Replace the Affordable Care Act.
American Health Care Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1628, American Health Care Act & HR 1628, Better Care Reconciliation Act and other efforts to Repeal & Replace the Affordable Care Act.
American Health Care Act of 2017
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1628 American Health Care Act and other efforts to repeal and replace ACA.
American Health Care Act of 2017
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1628 American Health Care Act and other efforts to repeal and replace ACA. HR 1628 Better Care Reconciliation Act
American Health Care Act of 2017
Client: THE HEMOPHILIA ALLIANCE · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act HR 1628 American Health Care Act and other efforts to repeal and replace ACA. HR 1628 Better Care Reconciliation Act
American Health Care Act of 2017
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act; HR 1628 American Health Care Act and other legislation to Repeal & Replace Affordable Care Act.
American Health Care Act of 2017
Client: ENDOCRINE SOCIETY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
American Health Care Act, HR 1628 Better Care Reconciliation Act
American Health Care Act of 2017
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act; HR 1628 American Health Care Act; HR 1628 Better Care Reconciliation Act and other legislation to Repeal & Replace Affordable Care Act.
American Health Care Act of 2017
Client: NATIONAL HEMOPHILIA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Implementation of the Affordable Care Act; HR 1628 American Health Care Act; HR 1628 Better Care Reconciliation Act and other legislation to Repeal & Replace Affordable Care Act.
American Health Care Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1628, American Health Care Act & other efforts to Repeal & Replace the Affordable Care Act.
Medicare reimbursement for physician and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule, CAR-T Therapy Coverage & Reimbursement S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 language on Medicare, Medicaid and other policy changes due to the COVID emergency.
Research in hematology
Efforts to repeal and/or replace Affordable Care Act S.1895 Lower Health Care Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2020 · first_quarter · 1T
Research and public health programs in epilepsy.
Healthcare issues related to the treatment of epilepsy.
Issues related to anti-epileptic drugs.
Funding for epilepsy programs at CDC, HRSA, NIH
Reimbursement for healthcare services provided by epilepsy centers;
Implementation of the Affordable Care Act
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2020 · first_quarter · 1T
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs.
Funding for Hemophilia program FY 2020 Labor, HHS and Education Appropriations
Implementation of the Affordable Care Act S 1895, Lower Healthcare Cost Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Hemophilia research, prevention, surveillance and service programs and issues
reimbursement for hemophilia services and treatments Medicaid reimbursement for treatments for hemophilia patients S.3233/HR5952 Hemophilia SNF Access Act. Medicare, Medicaid and other policy changes due to the COVID emergency. Medicare Coverage and Reimbursement of drugs Medicaid coverage policy S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Surprise medical billing
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2020 · first_quarter · 1T
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers S. 1895, Lower Healthcare Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Issues related to the 340B drug discount program and drug pricing policies
Hemophilia program funding
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug Reimbursement Drug Pricing Issues S.3233/HR5952 Hemophilia SNF Access ActS.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Medicare, Medicaid and other policy changes due to the COVID emergency
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · fourth_quarter · Q4
Research and public health programs in epilepsy.
Issues related to anti-epileptic drugs.
Funding for epilepsy programs at CDC, HRSA, NIH
Healthcare issues related to the treatment of epilepsy.
Implementation of the Affordable Care Act
Reimbursement for healthcare services provided by epilepsy centers; Medicare Physician Fee Schedule and Hospital Outpatient PPS 2020 Proposed Rules
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · fourth_quarter · Q4
Hemophilia research, prevention, surveillance and service programs and issues
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs.
reimbursement for hemophilia services and treatments Medicaid reimbursement for treatments for hemophilia patients Medicare Reimbursement of SNF services Medicare Coverage and Reimbursement of drugs Medicaid coverage policy S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Surprise medical billing
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · fourth_quarter · Q4
Hemophilia program funding
Issues related to the 340B drug discount program and drug pricing policies
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug Reimbursement Drug Pricing Issues Medicare Reimbursement of SNF Services S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · fourth_quarter · Q4
Efforts to repeal and/or replace Affordable Care Act S.1895 Lower Health Care Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Medicare reimbursement for physician and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule, CAR-T Therapy Coverage & Reimbursement S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Medicare Physician Fee Schedule for 2020 Proposed Rule
Hematology research, prevention and public health programs Sickle Cell Disease Surveillance, HRSA Demonstration program on Sickle Cell disease FY2020 Labor HHS Appropriations
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · third_quarter · Q3
Issues related to anti-epileptic drugs.
Implementation of the Affordable Care Act
Healthcare issues related to the treatment of epilepsy.
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · third_quarter · Q3
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug Reimbursement Drug Pricing Issues Medicare Reimbursement of SNF Services S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Hemophilia program funding
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers S. 1895, Lower Healthcare Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · third_quarter · Q3
reimbursement for hemophilia services and treatments Medicaid reimbursement for treatments for hemophilia patients Medicare Reimbursement of SNF services Medicare Coverage and Reimbursement of drugs Medicaid coverage policy S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs.
Hemophilia research, prevention, surveillance and service programs and issues
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · third_quarter · Q3
Research in hematology
Efforts to repeal and/or replace Affordable Care Act S.1895 Lower Health Care Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
HR 1409, Cancer Drug Coverage Parity Act
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · second_quarter · Q2
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers S. 1895, Lower Healthcare Costs Act
Issues related to the 340B drug discount program and drug pricing policies
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug Reimbursement Drug Pricing Issues Medicare Reimbursement of SNF Services
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · second_quarter · Q2
Research in hematology
Hematology research, prevention and public health programs Sickle Cell Disease Surveillance, HRSA Demonstration program on Sickle Cell disease FY2020 Labor HHS Appropriations
Efforts to repeal and/or replace Affordable Care Act S.1895 Lower Health Care Costs Act
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · second_quarter · Q2
Healthcare issues related to the treatment of epilepsy.
Funding for epilepsy programs at CDC, HRSA, NIH
Issues related to anti-epileptic drugs.
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · second_quarter · Q2
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs.
Funding for Hemophilia program FY 2020 Labor, HHS and Education Appropriations
reimbursement for hemophilia services and treatments Medicaid reimbursement for treatments for hemophilia patients Medicare Reimbursement of SNF services Medicare Coverage and Reimbursement of drugs
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · first_quarter · Q1
Funding for Hemophilia program FY 2020 Labor, HHS and Education Appropriations
Implementation of the Affordable Care Act HR 1010
reimbursement for hemophilia services and treatments Medicaid reimbursement for treatments for hemophilia patients
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · first_quarter · Q1
Issues related to anti-epileptic drugs.
Healthcare issues related to the treatment of epilepsy.
Implementation of the Affordable Care Act
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · first_quarter · Q1
Hemophilia program funding
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug Reimbursement Medicare Hospital Outpatient PPS Proposed Rule Drug Pricing Issues Medicare Reimbursement of SNF Services
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · first_quarter · Q1
Hematology research, prevention and public health programs Sickle Cell Disease Surveillance, HRSA Demonstration program on Sickle Cell disease FY2020 Labor HHS Appropriations
Efforts to repeal and/or replace Affordable Care Act
HR 1409, Cancer Drug Coverage Parity Act
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · fourth_quarter · Q4
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease; HR 2410/S 2465 SCD Research, Surveillance Prevention and Treatment Act of 2017
Hematology research, prevention and public health programs Sickle Cell Disease Surveillance
Medicare reimbursement for physician, and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · fourth_quarter · Q4
Hemophilia research, prevention, surveillance and service programs and issues.
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs.
Implementation of the Affordable Care Act S. 3388 - Ensuring Coverage for People with Pre-Existing Conditions Act
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · fourth_quarter · Q4
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug reimbursement Medicare Hospital Outpatient PPS proposed Rule International Drug Pricing Rule
Issues related to the 340B drug discount program and drug pricing policies
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · fourth_quarter · Q4
Issues related to anti-epileptic drugs.
Implementation of the Affordable Care Act
Funding for epilepsy programs at CDC, HRSA, NIH
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · third_quarter · Q3
Hemophilia research, prevention, surveillance and service programs and issues.
reimbursement for hemophilia services and treatments; Medicaid reimbursement for treatments for hemophilia patients
Implementation of the Affordable Care Act S. 3388 - Ensuring Coverage for People with Pre-Existing Conditions Act
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · third_quarter · Q3
Research and public health programs in epilepsy.
Implementation of the Affordable Care Act
Issues related to anti-epileptic drugs.
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · third_quarter · Q3
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug reimbursement Medicare Hospital Outpatient PPS proposed Rule
Issues related to the 340B drug discount program and drug pricing policies
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · third_quarter · Q3
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease; HR 2410/S 2465 SCD Research, Surveillance Prevention and Treatment Act of 2017
Efforts to repeal and/or replace Affordable Care Act.
Medicare reimbursement for physician, and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · second_quarter · Q2
Labor-HHS-Appropriations Act for FY 2019 Funding for Hemophilia programs
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs.
Hemophilia research, prevention, surveillance and service programs and issues.
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · second_quarter · Q2
Research and public health programs in epilepsy.
Issues related to anti-epileptic drugs.
Funding for epilepsy programs at CDC, HRSA, NIH
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · second_quarter · Q2
Labor-HHS-Education Appropriations Act 2019 Hemophilia program funding
Issues related to reimbursement for hemophilia services and treatments. Medicare Part B Drug reimbursement
Issues related to the 340B drug discount program
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · second_quarter · Q2
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease; HR 2410/S 2465 SCD Research, Surveillance Prevention and Treatment Act of 2017
Efforts to repeal and/or replace Affordable Care Act.
Medicare reimbursement for physician, and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · first_quarter · Q1
Issues related to the 340B drug discount program
Issues related to reimbursement for hemophilia services and treatments. Medicaid Outpatient Drug Rule; Medicare Part B Drug reimbursement
Implementation of the Affordable Care Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · first_quarter · Q1
Hemophilia research, prevention, surveillance and service programs and issues.
Implementation of the Affordable Care Act
reimbursement for hemophilia services and treatments; Medicaid reimbursement for treatments for hemophilia patients
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · first_quarter · Q1
Efforts to repeal and/or replace Affordable Care Act.
Medicare reimbursement for physician, and hematology services, sickle cell disease and bone marrow transplants
HR 1409, Cancer Drug Coverage Parity Act
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · first_quarter · Q1
Issues related to anti-epileptic drugs.
Healthcare issues related to the treatment of epilepsy.
Funding for epilepsy programs at CDC, HRSA, NIH
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · fourth_quarter · Q4
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease; HR 2410 SCD Research, Surveillance Prevention and Treatment Act of 2017
Medicare reimbursement for physician, and hematology services, sickle cell disease and bone marrow transplants
HR 1628, American Health Care Act & HR 1628, Better Care Reconciliation Act and other efforts to Repeal & Replace the Affordable Care Act.
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · fourth_quarter · Q4
Implementation of the Affordable Care Act
Reimbursement for healthcare services provided by epilepsy centers
Funding for epilepsy programs at CDC, HRSA, NIH
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · fourth_quarter · Q4
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs.
reimbursement for hemophilia services and treatments; Medicaid reimbursement for treatments for hemophilia patients
Implementation of the Affordable Care Act; HR 1628 American Health Care Act; HR 1628 Better Care Reconciliation Act and other legislation to Repeal & Replace Affordable Care Act.
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · fourth_quarter · Q4
Implementation of the Affordable Care Act HR 1628 American Health Care Act and other efforts to repeal and replace ACA. HR 1628 Better Care Reconciliation Act
Issues related to reimbursement for hemophilia services and treatments. Medicaid Outpatient Drug Rule; Medicare Part B Drug reimbursement
Issues related to the 340B drug discount program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · third_quarter · Q3
Implementation of the Affordable Care Act HR 1628 American Health Care Act and other efforts to repeal and replace ACA. HR 1628 Better Care Reconciliation Act
Issues related to reimbursement for hemophilia services and treatments. Medicaid Outpatient Drug Rule; Medicare Part B Drug reimbursement
Issues related to the 340B drug discount program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · third_quarter · Q3
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs.
Hemophilia research, prevention, surveillance and service programs and issues.
Implementation of the Affordable Care Act; HR 1628 American Health Care Act; HR 1628 Better Care Reconciliation Act and other legislation to Repeal & Replace Affordable Care Act.
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · third_quarter · Q3
Research and public health programs in epilepsy.
Implementation of the Affordable Care Act
Issues related to anti-epileptic drugs.
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · third_quarter · Q3
HR 1409, Cancer Drug Coverage Parity Act
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease; HR 2410 SCD Research, Surveillance Prevention and Treatment Act of 2017
Labor-HHS-Education Appropriations Act for FY 2018, HR 3358, S 1771 Hematology research, prevention and public health programs Sickle Cell Disease Surveillance
ENDOCRINE SOCIETY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · third_quarter · Q3
Medicare Reimbursement issues for physician services and diabetes care; meaningful use; chronic care reform proposals; Evaluation & Management code reform MACRA Implementation
Endocrine-Disrupting chemicals Personal Care Products Safety
Regulatory Accountability Act, S. 951
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · second_quarter · Q2
Reimbursement for healthcare services provided by epilepsy centers
Funding for epilepsy programs at CDC, HRSA, NIH
Issues related to anti-epileptic drugs.
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · second_quarter · Q2
Hemophilia research, prevention, surveillance and service programs and issues.
Implementation of the Affordable Care Act; HR 1628 American Health Care Act and other legislation to Repeal & Replace Affordable Care Act.
Labor-HHS-Appropriations Act for DY 2017 & 2018 Funding for Hemophilia programs
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · second_quarter · Q2
Issues related to the 340B drug discount program
Issues related to reimbursement for hemophilia services and treatments. Medicaid Outpatient Drug Rule; Medicare Part B Drug reimbursement
Implementation of the Affordable Care Act HR 1628 American Health Care Act and other efforts to repeal and replace ACA.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · second_quarter · Q2
Labor-HHS-Education Appropriations Act for FY 2017 & 2018 Hematology research, prevention and public health programs Sickle Cell Disease Surveillance
HR 1409, Cancer Drug Coverage Parity Act
Medicare reimbursement for physician, and hematology services, sickle cell disease and bone marrow transplants
ENDOCRINE SOCIETY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · second_quarter · Q2
Research in Endocrinology
Endocrine-Disrupting chemicals Personal Care Products Safety
Medicare Reimbursement issues for physician services and diabetes care; meaningful use; chronic care reform proposals; Evaluation & Management code reform MACRA Implementation
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · first_quarter · Q1
Issues related to anti-epileptic drugs.
Reimbursement for healthcare services provided by epilepsy centers
Funding for epilepsy programs at CDC, HRSA, NIH
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · first_quarter · Q1
Hemophilia research, prevention, surveillance and service programs and issues.
Labor-HHS-Appropriations Act for DY 2017 & 2018 Funding for Hemophilia programs
Implementation of the Affordable Care Act; HR 1628 American Health Care Act and other legislation to Repeal & Replace Affordable Care Act.
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · first_quarter · Q1
Issues related to reimbursement for hemophilia services and treatments. Medicaid Outpatient Drug Rule; Medicare Part B Drug reimbursement
Issues related to the 340B drug discount program
Implementation of the Affordable Care Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · first_quarter · Q1
HR 1409, Cancer Drug Coverage Parity Act
HR 1628, American Health Care Act & other efforts to Repeal & Replace the Affordable Care Act.
Labor-HHS-Education Appropriations Act for FY 2017 & 2018 Hematology research, prevention and public health programs
ENDOCRINE SOCIETY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · first_quarter · Q1
Medicare Reimbursement issues for physician services and diabetes care; meaningful use; chronic care reform proposals; Evaluation & Management code reform MACRA Implementation
Research in Endocrinology; Public Law No. 114-255; 21st Century Cures bill
Labor/HHS Appropriations for FY 2017 & 2018, Endocrine Research, physician-scientist workforce
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · fourth_quarter · Q4
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease. HR 1807, Sickle Cell Disease Research Surveillance Prevention and Treatment Act of 2015; Resolution on Sickle Cell Disease Trait
Departments of Labor, HHS, Education Appropriations Act for FY 2017, S.3040; no House bill number Hematology research, prevention and public health programs.
Medicare reimbursement for physician and hematology services
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · fourth_quarter · Q4
Issues related to reimbursement for hemophilia services and treatments. Medicaid Outpatient Drug Rule; Medicare Part B Drug Demonstration Rule
issues related to the 340B drug discount program
implementation of the Affordable Care Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
ENDOCRINE SOCIETY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · fourth_quarter · Q4
HR 2576, Toxic Chemical Safety Modernization Act of 2015; Endocrine-Disrupting chemicals S 697, Frank Lautenberg Chemical Safety Act for 21st Century; S. 1014 Personal Care Products Safety Act
Labor/HHS Appropriations for FY 2017, Endocrine Research, physician-scientist workforce
Research in Endocrinology; HR 6 House 21st Century Cures bill; Senate Innovations for Healthier Americans bill, S. 2745; HR 2101 Research for All act of 2015; inclusion in research; S. 1101 MEDTECH Act
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · fourth_quarter · Q4
Healthcare issues related to the treatment of epilepsy.
Issues related to anti-epileptic drugs.
Implementation of the Affordable Care Act
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · fourth_quarter · Q4
reimbursement for hemophilia services and treatments; Medicaid reimbursement for treatments for hemophilia patients.
Hemophilia research, prevention, surveillance and service programs and issues.
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program.
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · third_quarter · Q3
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program.
reimbursement for hemophilia services and treatments; Medicaid reimbursement for treatments for hemophilia patients.
Implementation of the Affordable Care Act and HR 3742, Access to Marketplace Insurance Act; HR 1600, Patients Access to Treatment Act
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · third_quarter · Q3
issues related to the 340B drug discount program
implementation of the Affordable Care Act
Issues related to reimbursement for hemophilia services and treatments. Medicaid Outpatient Drug Rule; Medicare Part B Drug Demonstration Rule
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · third_quarter · Q3
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease. HR 1807, Sickle Cell Disease Research Surveillance Prevention and Treatment Act of 2015; Resolution on Sickle Cell Disease Trait
Departments of Labor, HHS, Education Appropriations Act for FY 2017, S.3040; no House bill number Hematology research, prevention and public health programs.
HR 1600, Patient Access to Treatment Act; HR 2739 Cancer Drug Coverage Parity Act/S. 1566 Cancer Drug Coverage Parity Act
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · third_quarter · Q3
Healthcare issues related to the treatment of epilepsy.
Research and public health programs in epilepsy.
Reimbursement for healthcare services provided by epilepsy centers
ENDOCRINE SOCIETY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · third_quarter · Q3
Labor/HHS Appropriations for FY 2017, Endocrine Research, physician-scientist workforce
Medicare Reimbursement issues for physician services and diabetes care; meaningful use; chronic care reform proposals; Evaluation & Management code reform. HR 1427/ S 804, Medicare CGM Access Act.
Research in Endocrinology; HR 6 House 21st Century Cures bill; Senate Innovations for Healthier Americans bill, S. 2745; HR 2101 Research for All act of 2015; inclusion in research; S. 1101 MEDTECH Act
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · second_quarter · Q2
Reimbursement for healthcare services provided by epilepsy centers
Implementation of the Affordable Care Act
Issues related to anti-epileptic drugs.
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · second_quarter · Q2
implementation of the Affordable Care Act
Issues related to reimbursement for hemophilia services and treatments. Medicaid Outpatient Drug Rule; Medicare Part B Drug Demonstration Rule
issues related to the 340B drug discount program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · second_quarter · Q2
Implementation of the Affordable Care Act and HR 3742, Access to Marketplace Insurance Act; HR 1600, Patients Access to Treatment Act
Hemophilia research, prevention, surveillance and service programs and issues.
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program.
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · second_quarter · Q2
HR 1600, Patient Access to Treatment Act; HR 2739 Cancer Drug Coverage Parity Act/S. 1566 Cancer Drug Coverage Parity Act
Medicare reimbursement for physician and hematology services
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease.
ENDOCRINE SOCIETY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · second_quarter · Q2
HR 2576, Toxic Chemical Safety Modernization Act of 2015; Endocrine-Disrupting chemicals S 697, Frank Lautenberg Chemical Safety Act for 21st Century; S. 1014 Personal Care Products Safety Act
HR 2576, Toxic Chemical Safety Modernization Act of 2015; Endocrine-Disrupting chemicals S 697, Frank Lautenberg Chemical Safety Act for 21st Century; S. 1014 Personal Care Products Safety Act
Medicare Reimbursement issues for physician services and diabetes care; meaningful use; chronic care reform proposals; Evaluation & Management code reform.
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · first_quarter · Q1
Labor-HHS Appropriations Act for FY 2017
reimbursement for hemophilia services and treatments; Medicaid reimbursement for treatments for hemophilia patients.
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program. HR 1600, Patients Access to Treatment Act
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · first_quarter · Q1
Implementation of the Affordable Care Act
Research and public health programs in epilepsy.
Reimbursement for healthcare services provided by epilepsy centers
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · first_quarter · Q1
Departments of Labor, HHS, Education Appropriations Act for FY 2017 Hematology research, prevention and public health programs.
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease.
Medicare reimbursement for physician and hematology services
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · first_quarter · Q1
Issues related to reimbursement for hemophilia services and treatments. Medicaid Outpatient Drug Rule
issues related to the 340B drug discount program
implementation of the Affordable Care Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
ENDOCRINE SOCIETY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · first_quarter · Q1
Medicare Reimbursement issues for physician services and diabetes care; meaningful use; chronic care reform proposals; Evaluation & Management code reform.
HR 2576, Toxic Chemical Safety Modernization Act of 2015; Endocrine-Disrupting chemicals S 697, Frank Lautenberg Chemical Safety Act for 21st Century; S. 1014 Personal Care Products Safety Act
Labor/HHS Appropriations for FY 2017, Endocrine Research
ENDOCRINE SOCIETY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · fourth_quarter · Q4
HR 2576, Toxic Chemical Safety Modernization Act of 2015; Endocrine-Disrupting chemicals S 697, Frank Lautenberg Chemical Safety Act for 21st Century; S. 1014 Personal Care Products Safety Act
Research in Endocrinology; HR 6 House 21st Century Cures bill; Senate Innovations for Healthier Americans bill; HR 2101 Research for All act of 2015; sex differences in research.
HR 2576, Toxic Chemical Safety Modernization Act of 2015; Endocrine-Disrupting chemicals S 697, Frank Lautenberg Chemical Safety Act for 21st Century; S. 1014 Personal Care Products Safety Act
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · fourth_quarter · Q4
Labor-HHS Appropriations Act for FY 2016, S. 1695/no House bill # - hemophilia programs at CDC & HRSA and NIH.
Hemophilia research, prevention, surveillance and service programs and issues.
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program. HR 1600, Patients Access to Treatment Act
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · fourth_quarter · Q4
Research in hematology
HR 1600, Patient Access to Treatment Act; HR 2739 Cancer Drug Coverage Parity Act/S. 1566 Cancer Drug Coverage Parity Act
Medicare reimbursement for physician and hematology services
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · fourth_quarter · Q4
Issues related to anti-epileptic drugs.
Reimbursement for healthcare services provided by epilepsy centers
Healthcare issues related to the treatment of epilepsy.
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · fourth_quarter · Q4
Department of Labor, HHS, ED Appropriations Act for FY 2016, S. 1695/no House bill #
implementation of the Affordable Care Act
Issues related to reimbursement for hemophilia services and treatments.
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · third_quarter · Q3
Issues related to reimbursement for hemophilia services and treatments.
Department of Labor, HHS, ED Appropriations Act for FY 2016, S. 1695/no House bill #
issues related to the 340B drug discount program; HR 6, 21st Century Cures potential amendment
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · third_quarter · Q3
reimbursement for hemophilia services and treatments; reimbursement for treatments for SNF patients.
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program. HR 1600, Patients Access to Treatment Act
Implementation of the Affordable Care Act
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · third_quarter · Q3
Departments of Labor, HHS, Education Appropriations Act for FY 2016 - S. 1695/no House bill #, Hematology research, prevention and public health programs.
Research in hematology
HR 1600, Patient Access to Treatment Act; HR 2739 Cancer Drug Coverage Parity Act/S. 1566 Cancer Drug Coverage Parity Act
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · third_quarter · Q3
Implementation of the Affordable Care Act
Healthcare issues related to the treatment of epilepsy.
Funding for epilepsy programs at CDC, HRSA, NIH
ENDOCRINE SOCIETY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · third_quarter · Q3
Labor/HHS Appropriations for FY 2016, S. 1695/ no House Bill #, Endocrine Research
HR 2576, Toxic Chemical Safety Modernization Act of 2015; Endocrine-Disrupting chemicals S 697, Frank Lautenberg Chemical Safety Act for 21st Century; S. 1014 Personal Care Products Safety Act
HR 2576, Toxic Chemical Safety Modernization Act of 2015; Endocrine-Disrupting chemicals S 697, Frank Lautenberg Chemical Safety Act for 21st Century; S. 1014 Personal Care Products Safety Act
ENDOCRINE SOCIETY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · second_quarter · Q2
Medicare Reimbursement issues for physician services and diabetes care; HR 2 Medicare Access and CAIP Reauthorization Act.
HR 2576, Toxic Chemical Safety Modernization Act of 2015; Endocrine-Disrupting chemicals S 697, Frank Lautenberg Chemical Safety Act for 21st Century
HR 2576, Toxic Chemical Safety Modernization Act of 2015; Endocrine-Disrupting chemicals S 697, Frank Lautenberg Chemical Safety Act for 21st Century
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · second_quarter · Q2
Healthcare issues related to the treatment of epilepsy.
Issues related to anti-epileptic drugs.
Funding for epilepsy programs at CDC, HRSA, NIH
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · second_quarter · Q2
Hemophilia research, prevention, surveillance and service programs and issues.
reimbursement for hemophilia services and treatments; reimbursement for treatments for SNF patients.
Labor-HHS Appropriations Act for FY 2016, S. 1695/no House bill # - hemophilia programs at CDC & HRSA and NIH.
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · second_quarter · Q2
Medicare reimbursement for physician and hematology services
HR 1600, Patient Access to Treatment Act; HR 2739 Cancer Drug Coverage Parity Act/S. 1566 Cancer Drug Coverage Parity Act
Research in hematology
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · second_quarter · Q2
Issues related to reimbursement for hemophilia services and treatments.
issues related to the 340B drug discount program; HR 6, 21st Century Cures potential amendment
implementation of the Affordable Care Act
ENDOCRINE SOCIETY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · first_quarter · Q1
Research in Endocrinology; House 21st Century Cures bill; Senate Innovations for Healthier Americans bill; Sex Differences in research.
Toxic Chemical Safety Act; Endocrine disruptive chemicals
Medicare Reimbursement issues for physician services and diabetes care; HR 2 Medicare Access and CAIP Reauthorization Act.
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · first_quarter · Q1
Research in hematology
Departments of Labor, HHS, Education Appropriations Act for FY 2016, Hematology research, prevention and public health programs.
HR 1600, Patient Access to Treatment Act; HR 1801 Cancer Drug Coverage Parity Act/S. 1989 Cancer Treatment Parity Act
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · first_quarter · Q1
Reimbursement for healthcare services provided by epilepsy centers
Issues related to anti-epileptic drugs.
Implementation of the Affordable Care Act
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · first_quarter · Q1
Labor-HHS Appropriations Act for FY 2016 - hemophilia programs at CDC & HRSA and NIH.
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program. HR 1600, Patients Access to Treatment Act
Implementation of the Affordable Care Act
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · first_quarter · Q1
implementation of the Affordable Care Act
issues related to the 340B drug discount program
Issues related to reimbursement for hemophilia services and treatments.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
ENDOCRINE SOCIETY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · first_quarter · RR
Research and public health issues related to endocrinology, physician practice and reimbursement issues.
Research and public health issues related to endocrinology, physician practice and reimbursement issues.
Research and public health issues related to endocrinology, physician practice and reimbursement issues.
THE HEMOPHILIA ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2014 · fourth_quarter · Q4
Issues related to reimbursement for hemophilia services and treatments
Implementation of the Affordable Care Act
issues related to the 340B drug discount program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
NATIONAL HEMOPHILIA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2014 · fourth_quarter · Q4
Hemophilia research, prevention, surveillance and service programs and issues.
Labor-HHS Appropriations Act for FY 2015 - hemophilia programs at CDC & HRSA
Implementation of the Affordable Care Act
NATIONAL ASSOCIATION OF EPILEPSY CENTERS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2014 · fourth_quarter · Q4
reimbursement for healthcare services provided by epilepsy centers
Funding for epilepsy programs at CDC, HRSA, NIH
Research and public health programs in epilepsy.
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2014 · fourth_quarter · Q4
Departments of Labor, HHS, Education Appropriations Act for FY 2015, Hematology research, prevention and public health programs.
Medicare reimbursement for physician and hematology services
Research in hematology
Funding for Hemophilia program FY 2020 Labor, HHS and Education Appropriations
Implementation of the Affordable Care Act S 1895, Lower Healthcare Cost Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Implementation of the Affordable Care Act Issues related to Pharmacy Benefit Managers and Insurance company mergers S. 1895, Lower Healthcare Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
HR 1409, Cancer Drug Coverage Parity Act
Research in hematology
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Reimbursement for healthcare services provided by epilepsy centers; modernizing PART D and Medicare Advantage Rule Medicare Physician Fee Schedule and Hospital Outpatient PPS 2020 Proposed Rules
Funding for epilepsy programs at CDC, HRSA, NIH
Research and public health programs in epilepsy.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Issues related to the 340B drug discount program and drug pricing policies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lower Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 SJ Res 52; Public Charge
Funding for Hemophilia program FY 2020 Labor, HHS and Education Appropriations
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Hematology research, prevention and public health programs Sickle Cell Disease Surveillance, HRSA Demonstration program on Sickle Cell disease FY2020 Labor HHS Appropriations
Medicare reimbursement for physician and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule, CAR-T Therapy Coverage & Reimbursement S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 Medicare Physician Fee Schedule for 2020 Proposed Rule
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Hemophilia program funding
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
HR 1409, Cancer Drug Coverage Parity Act
Medicare reimbursement for physician and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule, CAR-T Therapy Coverage & Reimbursement
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Reimbursement for healthcare services provided by epilepsy centers; modernizing PART D and Medicare Advantage Rule
Research and public health programs in epilepsy.
Implementation of the Affordable Care Act
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Hemophilia research, prevention, surveillance and service programs and issues
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lover Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs.
Hemophilia research, prevention, surveillance and service programs and issues
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Research and public health programs in epilepsy.
Funding for epilepsy programs at CDC, HRSA, NIH
Reimbursement for healthcare services provided by epilepsy centers; modernizing PART D and Medicare Advantage Rule
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Issues related to the 340B drug discount program and drug pricing policies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Medicare reimbursement for physician and hematology services, sickle cell disease and bone marrow transplants Medicare Inpatient PPS Proposed Rule, CAR-T Therapy Coverage & Reimbursement
Research in hematology
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
HR 1409, Cancer Drug Coverage Parity Act
Efforts to repeal and/or replace Affordable Care Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
reimbursement for hemophilia services and treatments; Medicaid reimbursement for treatments for hemophilia patients
Funding for Hemophilia programs
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Hemophilia program funding
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Research and public health programs in epilepsy.
Healthcare issues related to the treatment of epilepsy.
Reimbursement for healthcare services provided by epilepsy centers; modernizing PART D and Medicare Advantage Rule
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs.
H.R. 6157 Labor-HHS-Appropriations Act for FY 2019 Funding for Hemophilia programs
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Reimbursement for healthcare services provided by epilepsy centers
Funding for epilepsy programs at CDC, HRSA, NIH
Healthcare issues related to the treatment of epilepsy.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Labor-HHS-Education Appropriations Act 2019, HR 6157 Hemophilia program funding
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
HR 6157 - Department of Defense, Labor and HHS Appropriations Act, 2019 Hematology research, prevention and public health programs Sickle Cell Disease Surveillance
HR 1409, Cancer Drug Coverage Parity Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
reimbursement for hemophilia services and treatments; Medicaid reimbursement for treatments for hemophilia patients
Implementation of the Affordable Care Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Reimbursement for healthcare services provided by epilepsy centers
Healthcare issues related to the treatment of epilepsy.
Implementation of the Affordable Care Act
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Implementation of the Affordable Care Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
HR 1409, Cancer Drug Coverage Parity Act
Labor-HHS-Education Appropriations Act for FY 2019 Hematology research, prevention and public health programs Sickle Cell Disease Surveillance
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Labor-HHS-Appropriations Act for FY 2019 Funding for Hemophilia programs
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease; HR 2410/S 2465 SCD Research, Surveillance Prevention and Treatment Act of 2017
Labor-HHS-Education Appropriations Act for FY 2019 Hematology research, prevention and public health programs Sickle Cell Disease Surveillance
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Research and public health programs in epilepsy.
Implementation of the Affordable Care Act
Reimbursement for healthcare services provided by epilepsy centers
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Labor-HHS-Education Appropriations Act for FY 2018, HR 3358, S 1771 Hematology research, prevention and public health programs Sickle Cell Disease Surveillance
HR 1409, Cancer Drug Coverage Parity Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Issues related to anti-epileptic drugs.
Research and public health programs in epilepsy.
Healthcare issues related to the treatment of epilepsy.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Labor-HHS-Appropriations Act for FY 2018, HR 3358/ S 1771 Funding for Hemophilia programs
Hemophilia research, prevention, surveillance and service programs and issues.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
reimbursement for hemophilia services and treatments; Medicaid reimbursement for treatments for hemophilia patients
Labor-HHS-Appropriations Act for FY 2018, HR 3358/ S 1771 Funding for Hemophilia programs
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Funding for epilepsy programs at CDC, HRSA, NIH
Healthcare issues related to the treatment of epilepsy.
Reimbursement for healthcare services provided by epilepsy centers
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
HR 1628, American Health Care Act & HR 1628, Better Care Reconciliation Act and other efforts to Repeal & Replace the Affordable Care Act.
Medicare reimbursement for physician, and hematology services, sickle cell disease and bone marrow transplants
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Endocrine-Disrupting Chemicals Personal Care Products Safety
American Health Care Act, HR 1628 Better Care Reconciliation Act, HR 6628 Graham-Cassidy Special Diabetes Program
Research in Endocrinology
Labor/HHS Appropriations FY 2018, Endocrine Research, physician-scientist workforce H.R.3358/S.1771 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018
Filing targets: Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
Healthcare issues related to the treatment of epilepsy.
Implementation of the Affordable Care Act
Research and public health programs in epilepsy.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
reimbursement for hemophilia services and treatments; Medicaid reimbursement for treatments for hemophilia patients
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease; HR 2410 SCD Research, Surveillance Prevention and Treatment Act of 2017
HR 1628, American Health Care Act & other efforts to Repeal & Replace the Affordable Care Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Endocrine-Disrupting Chemicals Personal Care Products Safety
Labor/HHS Appropriations for FY 2017 & 2018, Endocrine Research, physician-scientist workforce
Regulatory Accountability Act, S. 951
American Health Care Act, HR 1628 Better Care Reconciliation Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
Research and public health programs in epilepsy.
Healthcare issues related to the treatment of epilepsy.
Implementation of the Affordable Care Act
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
reimbursement for hemophilia services and treatments; Medicaid reimbursement for treatments for hemophilia patients
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease.
Medicare reimbursement for physician and hematology services
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Endocrine-Disrupting Chemicals Personal Care Products Safety
Endocrine-Disrupting chemicals Personal Care Products Safety
Filing targets: Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
HR 1600, Patient Access to Treatment Act; HR 2739 Cancer Drug Coverage Parity Act/S. 1566 Cancer Drug Coverage Parity Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
HR 2576, Toxic Chemical Safety Modernization Act of 2015; Endocrine-Disrupting chemicals S 697, Frank Lautenberg Chemical Safety Act for 21st Century; S. 1014 Personal Care Products Safety Act
Medicare Reimbursement issues for physician services and diabetes care; meaningful use; chronic care reform proposals; Evaluation & Management code reform. HR 1427/ S 804, Medicare CGM Access Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
Reimbursement for healthcare services provided by epilepsy centers
Research and public health programs in epilepsy.
Funding for epilepsy programs at CDC, HRSA, NIH
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Implementation of the Affordable Care Act and HR 3742, Access to Marketplace Insurance Act; HR 1600, Patients Access to Treatment Act
Labor-HHS Appropriations Act for FY 2017
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
Hemophilia research, prevention, surveillance and service programs and issues.
Labor-HHS Appropriations Act for FY 2017
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
Medicare reimbursement for physician and hematology services
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Funding for epilepsy programs at CDC, HRSA, NIH
Implementation of the Affordable Care Act
Issues related to anti-epileptic drugs.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
HR 2576, Toxic Chemical Safety Modernization Act of 2015; Endocrine-Disrupting chemicals S 697, Frank Lautenberg Chemical Safety Act for 21st Century; S. 1014 Personal Care Products Safety Act
HR 2576, Toxic Chemical Safety Modernization Act of 2015; Endocrine-Disrupting chemicals S 697, Frank Lautenberg Chemical Safety Act for 21st Century; S. 1014 Personal Care Products Safety Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
Research and public health programs in epilepsy.
Funding for epilepsy programs at CDC, HRSA, NIH
Healthcare issues related to the treatment of epilepsy.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
reimbursement for hemophilia services and treatments; Medicaid reimbursement for treatments for hemophilia patients.
Labor-HHS Appropriations Act for FY 2017
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
Departments of Labor, HHS, Education Appropriations Act for FY 2017, S.3040; no House bill number Hematology research, prevention and public health programs.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Labor/HHS Appropriations for FY 2017, Endocrine Research, physician-scientist workforce
Research in Endocrinology; HR 6 House 21st Century Cures bill; Senate Innovations for Healthier Americans bill, S. 2745; HR 2101 Research for All act of 2015; inclusion in research; S. 1101 MEDTECH Act, HR 1427/ S 804, Medicare CGM Access Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
Implementation of the Affordable Care Act
Hemophilia research, prevention, surveillance and service programs and issues.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
Healthcare issues related to the treatment of epilepsy.
Issues related to anti-epileptic drugs.
Funding for epilepsy programs at CDC, HRSA, NIH
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
HR 1600, Patient Access to Treatment Act; HR 2739 Cancer Drug Coverage Parity Act/S. 1566 Cancer Drug Coverage Parity Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Research in Endocrinology; HR 6 House 21st Century Cures bill; Senate Innovations for Healthier Americans bill, S. 2745; HR 2101 Research for All act of 2015; inclusion in research; S. 1101 MEDTECH Act.
HR 2576, Toxic Chemical Safety Modernization Act of 2015; Endocrine-Disrupting chemicals S 697, Frank Lautenberg Chemical Safety Act for 21st Century; S. 1014 Personal Care Products Safety Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
Labor/HHS Appropriations for FY 2016, S. 1695/ no House Bill #, Endocrine Research
Medicare Reimbursement issues for physician services and diabetes care; meaningful use
Filing targets: Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
Implementation of the Affordable Care Act
reimbursement for hemophilia services and treatments; reimbursement for treatments for SNF patients.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
Departments of Labor, HHS, Education Appropriations Act for FY 2016 - S. 1695/no House bill #, Hematology research, prevention and public health programs.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Funding for epilepsy programs at CDC, HRSA, NIH
Research and public health programs in epilepsy.
Implementation of the Affordable Care Act
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
issues related to the 340B drug discount program; HR 6, 21st Century Cures potential amendment
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
implementation of the Affordable Care Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Hemophilia research, prevention, surveillance and service programs and issues.
Labor-HHS Appropriations Act for FY 2016, S. 1695/no House bill # - hemophilia programs at CDC & HRSA and NIH.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
Medicare reimbursement for physician and hematology services
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Reimbursement for healthcare services provided by epilepsy centers
Issues related to anti-epileptic drugs.
Research and public health programs in epilepsy.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Medicare Reimbursement issues for physician services and diabetes care; meaningful use
Research in Endocrinology; HR 6 House 21st Century Cures bill; Senate Innovations for Healthier Americans bill; HR 2101 Research for All act of 2015; sex differences in research.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
Labor/HHS Appropriations for FY 2016, S. 1695/ no House Bill #, Endocrine Research
Research in Endocrinology; HR 6 House 21st Century Cures bill; Senate Innovations for Healthier Americans bill; HR 2101 Research for All act of 2015; sex differences in research.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
Reimbursement for healthcare services provided by epilepsy centers
Research and public health programs in epilepsy.
Implementation of the Affordable Care Act
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program. HR 1600, Patients Access to Treatment Act
Implementation of the Affordable Care Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
Departments of Labor, HHS, Education Appropriations Act for FY 2016 - S. 1695/no House bill #, Hematology research, prevention and public health programs.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Department of Labor, HHS, ED Appropriations Act for FY 2016, S. 1695/no House bill #
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Toxic Chemical Safety Act; Endocrine-Disrupting chemicals
Labor/HHS Appropriations for FY 2016, Endocrine Research
Filing targets: Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
Medicare reimbursement for physician and hematology services
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Healthcare issues related to the treatment of epilepsy.
Funding for epilepsy programs at CDC, HRSA, NIH
Research and public health programs in epilepsy.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
reimbursement for hemophilia services and treatments; reimbursement for treatments for SNF patients.
Hemophilia research, prevention, surveillance and service programs and issues.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
Research and public health issues related to endocrinology, physician practice and reimbursement issues.
reimbursement for hemophilia services and treatments
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program. HR 460 Patients Access to Treatment Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
Implementation of the Affordable Care Act
Healthcare issues related to the treatment of epilepsy.
Issues related to anti-epileptic drugs
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
HR 460, Patient Access to Treatment Act; HR 1801 Cancer Drug Coverage Parity Act/S. 1989 Cancer Treatment Parity Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE